• Record: found
  • Abstract: found
  • Article: found

Optical Coherence Tomography Angiography Using the Optovue Device

Read this article at

      There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


      Optovue AngioVue system technology for optical coherence tomography (OCT) angiography is based on the AngioVue Imaging System (Optovue, Inc., Freemont, CA), using split-spectrum amplitude-decorrelation angiography (SSADA) algorithm. This algorithm was developed to minimize scanning time. It detects motion in blood vessel lumen by measuring the variation in reflected OCT signal amplitude between consecutive cross-sectional scans. The novelty of SSADA lies in how the OCT signal is processed to enhance flow detection and reject axial bulk motion noise. Specifically, the algorithm splits the OCT image into different spectral bands, thus increasing the number of usable image frames. Each new frame has a lower axial resolution that is less susceptible to axial eye motion caused by blood pulsation. Optovue AngioVue system technology allows quantitative analysis. It provides numerical data about flow area and non-flow area. It can also generate a flow density map. These metrics may serve as biomarkers in diagnosis and for tracking disease progression or treatment response. Flow area: the software will calculate the drawn area and vessel area in mm 2. It allows for comparison of all measurements for a given participant. Non-flow area: the software shows the non-perfused areas by mouse click selection. Ischemic areas will be shown in yellow. These areas may be saved and matched with others in the study. Flow density tool is able to measure the percentage of vascular areas on en face angiograms. This analysis is based on an ETDRS grid centered on the macula as with the thickness map. This tool works both on inner and outer vascular plexus.

      Related collections

      Most cited references 12

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Split-spectrum amplitude-decorrelation angiography with optical coherence tomography

      Amplitude decorrelation measurement is sensitive to transverse flow and immune to phase noise in comparison to Doppler and other phase-based approaches. However, the high axial resolution of OCT makes it very sensitive to the pulsatile bulk motion noise in the axial direction. To overcome this limitation, we developed split-spectrum amplitude-decorrelation angiography (SSADA) to improve the signal-to-noise ratio (SNR) of flow detection. The full OCT spectrum was split into several narrower bands. Inter-B-scan decorrelation was computed using the spectral bands separately and then averaged. The SSADA algorithm was tested on in vivo images of the human macula and optic nerve head. It significantly improved both SNR for flow detection and connectivity of microvascular network when compared to other amplitude-decorrelation algorithms.
        • Record: found
        • Abstract: found
        • Article: not found

        Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration.

        To detect and quantify choroidal neovascularization (CNV) in patients with age-related macular degeneration (AMD) using optical coherence tomography (OCT) angiography. Observational, cross-sectional study. A total of 5 normal subjects and 5 subjects with neovascular AMD were included. A total of 5 eyes with neovascular AMD and 5 normal age-matched controls were scanned by a high-speed (100 000 A-scans/seconds) 1050-nm wavelength swept-source OCT. The macular angiography scan covered a 3 × 3-mm area and comprised 200 × 200 × 8 A-scans acquired in 3.5 seconds. Flow was detected using the split-spectrum amplitude-decorrelation angiography (SSADA) algorithm. Motion artifacts were removed by 3-dimensional (3D) orthogonal registration and merging of 4 scans. The 3D angiography was segmented into 3 layers: inner retina (to show retinal vasculature), outer retina (to identify CNV), and choroid. En face maximum projection was used to obtain 2-dimensional angiograms from the 3 layers. The CNV area and flow index were computed from the en face OCT angiogram of the outer retinal layer. Flow (decorrelation) and structural data were combined in composite color angiograms for both en face and cross-sectional views. The CNV angiogram, CNV area, and CNV flow index. En face OCT angiograms of CNV showed sizes and locations that were confirmed by fluorescein angiography (FA). Optical coherence tomography angiography provided more distinct vascular network patterns that were less obscured by subretinal hemorrhage. The en face angiograms also showed areas of reduced choroidal flow adjacent to the CNV in all cases and significantly reduced retinal flow in 1 case. Cross-sectional angiograms were used to visualize CNV location relative to the retinal pigment epithelium and Bruch's layer and classify type I and type II CNV. A feeder vessel could be identified in 1 case. Higher flow indexes were associated with larger CNV and type II CNV. Optical coherence tomography angiography provides depth-resolved information and detailed images of CNV in neovascular AMD. Quantitative information regarding CNV flow and area can be obtained. Further studies are needed to assess the role of quantitative OCT angiography in the evaluation and treatment of neovascular AMD. Copyright © 2014 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
          • Record: found
          • Abstract: found
          • Article: not found

          Optical coherence tomography angiography of optic disc perfusion in glaucoma.

          To compare optic disc perfusion between normal subjects and subjects with glaucoma using optical coherence tomography (OCT) angiography and to detect optic disc perfusion changes in glaucoma.

            Author and article information

            aCasey Eye Institute, Oregon Health and Science University, Portland, Oreg., USA; bCentro Italiano Macula, Rome, Italy
            Dev Ophthalmol
            Developments in Ophthalmology
            Dev Ophthalmol
            S. Karger AG (Basel, Switzerland karger@ )
            March 2016
            15 March 2016
            : 56
            : OCT Angiography in Retinal and Macular Diseases
            : 6-12
            DOP2016056006 10.1159/000442770 27022989 Bandello F, Souied EH, Querques G (eds): OCT Angiography in Retinal and Macular Diseases. Dev Ophthalmol. Basel, Karger, 2016, vol 56, pp 6-12
            © 2016 S. Karger AG, Basel

            Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

            Figures: 3, References: 25, Pages: 7

            Medicine, General social science


            Comment on this article